Aug 22 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO :
* Valeant pharmaceuticals appoints Paul S. Herendeen as executive vice president, finance and chief financial officer
* Herendeen will take over role of chief financial officer from Robert L. Rosiello effective immediately
* Prior to joining Valeant, Herendeen served as executive vice president and chief financial officer of Zoetis Inc (NYSE:ZTS). For two years
* Rosiello will assume responsibility for corporate development and strategy and continues as evp and an executive committee member Source text for Eikon: ID:nCNWmWBfDa Further company coverage: VRX.TO